Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Nass R;Nass R; Hall DH; Miller DM 3rd; Blakely RD
- Source:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2002 Mar 05; Vol. 99 (5), pp. 3264-9. Date of Electronic Publication: 2002 Feb 26.
- Publication Type:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
- Language:
English
- Additional Information
- Source:
Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0027-8424 (Print) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE
- Publication Information:
Original Publication: Washington, DC : National Academy of Sciences
- Subject Terms:
- Abstract:
Parkinson's disease is a complex neurodegenerative disorder characterized by the death of brain dopamine neurons. In mammals, dopamine neuronal degeneration can be triggered through exposure to neurotoxins accumulated by the presynaptic dopamine transporter (DAT), including 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenylpyridinium. We have established a system for the pharmacological and genetic evaluation of neurotoxin-induced dopamine neuronal death in Caenorhabditis elegans. Brief (1 h) exposure of green fluorescent protein-tagged, living worms to 6-OHDA causes selective degeneration of dopamine neurons. We demonstrate that agents that interfere with DAT function protect against 6-OHDA toxicity. 6-OHDA-triggered neural degeneration does not require the CED-3/CED-4 cell death pathway, but is abolished by the genetic disruption of the C. elegans DAT.
- References:
Cell. 1993 Nov 19;75(4):641-52. (PMID: 8242740)
Science. 1996 Nov 22;274(5291):1389-91. (PMID: 8910282)
J Comp Neurol. 1975 Sep 15;163(2):215-26. (PMID: 240872)
Science. 2001 Nov 9;294(5545):1346-9. (PMID: 11701929)
Genes Dev. 1999 Nov 1;13(21):2774-86. (PMID: 10557206)
Synapse. 2000 Sep 1;37(3):171-8. (PMID: 10881039)
FASEB J. 2001 Apr;15(6):916-26. (PMID: 11292651)
Mov Disord. 1998;13 Suppl 1:24-34. (PMID: 9613715)
J Neurocytol. 1996 Dec;25(12):843-56. (PMID: 9023729)
J Neural Transm Suppl. 1995;46:297-314. (PMID: 8821067)
Pharmacol Biochem Behav. 1980 Dec;13(6):915-7. (PMID: 7193877)
Nat Neurosci. 2000 Dec;3(12):1301-6. (PMID: 11100151)
Genetics. 1974 May;77(1):71-94. (PMID: 4366476)
J Chromatogr. 1974 Nov 6;99(0):529-40. (PMID: 4153550)
Nature. 1998 Apr 9;392(6676):605-8. (PMID: 9560156)
Philos Trans R Soc Lond B Biol Sci. 1986 Nov 12;314(1165):1-340. (PMID: 22462104)
Nat Genet. 1995 Nov;11(3):309-13. (PMID: 7581455)
J Neurosci Res. 1999 Jul 1;57(1):86-94. (PMID: 10397638)
Neuron. 2000 Jun;26(3):619-31. (PMID: 10896158)
Science. 1997 Jun 27;276(5321):2045-7. (PMID: 9197268)
J Neurosci. 1999 Feb 15;19(4):1284-93. (PMID: 9952406)
Nature. 2000 Feb 3;403(6769):560-4. (PMID: 10676966)
J Neural Transm Suppl. 1997;50:55-66. (PMID: 9120425)
J Neurosci. 1997 Feb 1;17(3):1033-45. (PMID: 8994058)
Biochem Pharmacol. 1975 Jan 1;24(1):1-8. (PMID: 1092302)
Dev Biol. 1977 Mar;56(1):110-56. (PMID: 838129)
J Neurosci. 2001 Aug 15;21(16):5871-84. (PMID: 11487610)
J Biol Chem. 1998 Dec 25;273(52):35109-17. (PMID: 9857046)
Nature. 1995 May 4;375(6526):73-8. (PMID: 7723846)
Parkinsonism Relat Disord. 2001 Jul;7(3):185-191. (PMID: 11331185)
J Neural Transm (Vienna). 2000;107(1):1-29. (PMID: 10809400)
Ann Neurol. 1998 May;43(5):555-60. (PMID: 9585349)
Neurochem Res. 1993 Nov;18(11):1175-7. (PMID: 8255370)
Development. 1992 Oct;116(2):309-20. (PMID: 1286611)
Methods Cell Biol. 1995;48:451-82. (PMID: 8531738)
Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173-7. (PMID: 3872460)
Brain Res Mol Brain Res. 1999 Jan 22;64(1):141-8. (PMID: 9889353)
Cell Death Differ. 1999 Jun;6(6):516-24. (PMID: 10381654)
Nature. 2000 Mar 23;404(6776):394-8. (PMID: 10746727)
Methods Cell Biol. 1995;48:3-29. (PMID: 8531730)
J Neurosci. 1996 Jan 15;16(2):436-47. (PMID: 8551328)
Mol Cell Biol. 1990 May;10(5):2081-9. (PMID: 1970117)
J Neurosci. 1999 Jan 1;19(1):72-84. (PMID: 9870940)
Genetics. 1999 Dec;153(4):1655-71. (PMID: 10581274)
J Biol Chem. 1994 Jun 10;269(23):15985-8. (PMID: 8206893)
Mol Pharmacol. 1998 Oct;54(4):601-9. (PMID: 9765501)
Nature. 1994 Mar 3;368(6466):32-8. (PMID: 7906398)
- Grant Information:
R24 OD010943 United States OD NIH HHS; T32 MH019732 United States MH NIMH NIH HHS; R24 RR012596 United States RR NCRR NIH HHS; P30 DK020593 United States DK NIDDK NIH HHS; RR12596 United States RR NCRR NIH HHS; P01DK58212 United States DK NIDDK NIH HHS; CA68485 United States CA NCI NIH HHS; DK20593 United States DK NIDDK NIH HHS; P01 DK058212 United States DK NIDDK NIH HHS; P30 CA068485 United States CA NCI NIH HHS; MH19732-07 United States MH NIMH NIH HHS
- Accession Number:
0 (Caenorhabditis elegans Proteins)
0 (Calcium-Binding Proteins)
0 (Ced-4 protein, C elegans)
0 (Dopamine Plasma Membrane Transport Proteins)
0 (Helminth Proteins)
0 (Membrane Glycoproteins)
0 (Membrane Transport Proteins)
0 (Nerve Tissue Proteins)
0 (Neurotoxins)
8HW4YBZ748 (Oxidopamine)
EC 3.4.22.- (Caspases)
EC 3.4.22.- (ced-3 protein, C elegans)
VTD58H1Z2X (Dopamine)
- Publication Date:
Date Created: 20020228 Date Completed: 20020426 Latest Revision: 20221101
- Publication Date:
20221213
- Accession Number:
PMC122507
- Accession Number:
10.1073/pnas.042497999
- Accession Number:
11867711
No Comments.